COPD

The FDA approved this nebulized long-acting muscarinic antagonist in December 2017, and it is expected to be launched this spring.

Up to 80% of women experience gastro-esophageal reflux disease during pregnancy.

Tiotropiumis is an inhaled anticholinergic bronchodilator approved by the FDA for long-term use in patients with asthma and COPD.

Excess weight may exacerbate asthma symptoms without affecting the efficacy of inhaled corticosteroids.

Glycopyrrolate inhalation solution is the first nebulized long-acting muscarinic antagonist for the treatment of chronic obstructive pulmonary disease.

The FDA has approved glycopyrrolate (Lonhala Magnair, Sunovion) inhalation solution, also known as SUN-101/eFlow, the first nebulized long-acting muscarinic antagonist (LAMA) for the treatment of chronic obstructive pulmonary disease (COPD).

The medication is indicated for the long-term, once-daily maintenance treatment of patients with chronic obstructive pulmonary disease.

Trelegy Ellipta is a combination of an inhaled corticosteroid, a long-acting muscarinic antagonist, and a long-acting beta2-adrenergic agonist for chronic obstructive pulmonary disease.

Chronic obstructive pulmonary disease (COPD)—irreversible—requires long-term adherence to pharmacotherapies for best outcomes.

Does this represent an opportunity for pharmacists to use such devices to help monitor adherence in patients?

Nucala is an interleukin-5 antagonist under consideration as an add-on maintenance therapy for certain patients with chronic obstructive pulmonary disease.

High-dose omega-3 fatty acids during the third trimester of pregnancy could prevent respiratory problems.

Dupilumab is a monoclonal antibody previously approved to treat moderate-to-severe atopic dermatitis.

Many children with HIV who are diagnosed with asthma may actually have chronic obstructive lung disease.

Trial to analyze which commonly prescribed therapies can reduce exacerbations in patients with chronic obstructive pulmonary disease.

Concerns persist that excess folic acid supplementation may cause asthma in young children.

Healthcare workers may be at risk of chronic obstructive pulmonary disease due to exposure to cleaning products.

Exposing infants to high indoor levels of certain allergens may have a preventive effect on the development of asthma

Officials with the FDA have approved fluticasone furoate/umeclidinium/vilanterol (FF/UMEC/VI) (Trelegy Ellipta, GlaxoSmithKline and Innoviva), for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).

Fluticasone furoate/umeclidinium/vilanterol (Trelegy Ellipta) is a single-inhaler triple therapy for the long-term, maintenance treatment of patients with chronic obstructive pulmonary disease.

Interventions to address asthma symptoms include allergen sensitivity testing and exposure remediation.

The thing is, you still may get sick after getting the flu because there are other things such as the common cold that might cross your path.

The cost and adverse events associated with corticosteroids need to be considered for patients with severe asthma.

Instructional methods can improve effectiveness of hand-held inhalers for asthma and chronic obstructive pulmonary disease.

Population growth and aging cause increase in disease burden from asthma and chronic obstructive pulmonary disease.

The prevalence of lung conditions worldwide has increased, despite the overall decrease in the prevalence and death rates for asthma between 1990 and 2015, according to the results of the 2015 Global Burden of Disease (GBD) Study.

Conclusive evidence that supports the use of probiotics to prevent eczema and asthma in high-risk infants is lacking.

Some patients with asthma have symptoms uncontrolled by inhaled corticosteroids and long-acting bronchodilators.

Patients with chronic obstructive pulmonary disease often have difficulty adhering to medications, which can lead to hospitalization.

Patients with chronic obstructive pulmonary disease (COPD) often have difficulty adhering to medications, leading to exacerbations, and often hospitalization.